Clinical Trials
16 trialsNCT07513259 2026-04-07
Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes
Chung Shan Medical University
Completed
NCT07332156 2026-01-14
Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
Samsung Medical Center
Completed
NCT05687474 2025-08-12
BabyDetect
Centre Hospitalier Universitaire de Liege
Completed
NCT03464045 2025-04-20
Empa PASS on Urinary Tract Malignancies
Boehringer Ingelheim
Completed
NCT06583161 2024-09-03
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
Harvard School of Public Health (HSPH)
Completed
NCT06480058 2024-06-28
BariPredict
Kuwait University
Completed
NCT04670094 2022-11-09
Comorbidities
University of Milano Bicocca
Completed
NCT04548232 2022-09-14
Clinical Efficacy and Safety of a Laparoscopic Sleeve Gastrectomy in Obese Patients
Shanghai 10th People's Hospital
Completed
NCT04767750 2022-04-07
Role of LncRNA H19 in The Regulation of IGF-1R Expression
Mansoura University
Completed
NCT01935466 2022-01-25
PROBE-PIO
Post Graduate Institute of Medical Education and Research, Chandigarh
Completed
NCT01647776 2021-02-09
Screening and Risk Factors of Colon Neoplasia
Case Comprehensive Cancer Center
Completed
NCT02475499 2016-03-14
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES
Completed
NCT02608853 2015-11-20
Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADERâ„¢ Trial Participants
Novo Nordisk A/S
Completed
NCT01195259 2013-10-28
Malignancy Meta Analysis for BRL49653
GlaxoSmithKline
Completed
NCT00782366 2011-04-27
PGT
Mayo Clinic
Completed
NCT00145392 2008-06-24
Body Composition, Glucose Metabolism, Insulin Resistance and Gene Expression in Muscle Cells in Healthy Overweight Women
Odense University Hospital
Completed